Dr. Ken Morse (ケン・モース)

Senior Lecturer and Managing Director,  MIT Entrepreneurship Center

Ken Morse leads the MIT effort to train leaders to bring innovative concepts and technologies to market and build successful high tech startup businesses.  Based at the MIT Sloan School of Management, the MIT Entrepreneurship Center has the mandate to teach High Tech Entrepreneurship and to foster research and collaboration, Institute-wide.  The student-run $50K Entrepreneurship Competition, as well as enrollment in New Enterprises and the Entrepreneurship Laboratory Courses, are open to students from Engineering, Science, and Management, encouraging multidisciplinary teamwork.  Morse joined MIT in 1996 after 25 years as a serial entrepreneur helping launch six high-tech ventures.

Between 1982 and 1996, Morse held a number of strategic positions in a venture-backed startup, Aspen Technology, Inc., which commercialized process modeling software originally developed at MMIT.  He initially crafted the company’s global strategy and secured early customers in Europe and Asia.  As a member of AspenTech’s Board of Directors from 1986 until 1995, he focused on AspenTech’s entry into new global markets, including high value applications of their enterprise software.  From 1992 to 1996, he resided in Brussels as AspenTech’s Managing Director for Europe, Middle East and Africa where he opened and managed new offices in France, Germany, Italy, Switzerland and South Africa, as well as integrating the European businesses acquired by AspenTech.

After a highly successful initial public offering (IPO) in October 1994, AspenTech has grown to 1600+ employees worldwide, with revenues exceeding $150 million.  Morse continues to advise AspenTech on global new business initiatives, particularly in supply chain management for the Chemical, Pharmaceutical, and Pulp and Paper industries.

Ken’s interest in international high tech ventures began at MIT, where he graduated with a BS in Political Science in 1968.  Following graduation, as President of AIESEC-US and an International Advisory Committee Officer for this global business student exchange program, he traveled widely on behalf of AIESEC before entering Harvard Business School.  Morse received his MBA with honors in 1972 and joined Schroders, the UK-based merchant bank, where he worked directly for Jim Wolfensohn, now President of the World Bank.

In 1975 Morse formed a trading company under the aegis of Chase Manhattan Bank to assist U.S. technology-based companies to enter emerging Asian markets.  He lived in Beijing for five years during the latter half of the Cultural Revolution.  As President of Chase Pacific Trade Advisors, he assisted IBM, General Motors, Hughes Aircraft, Measurex, Mine Safety Appliances, and Waters Associates to enter China and other developing markets.

In 1980, Morse relocated to Silicon Valley as a founding member of  3Com Corporation, where he was employee #8.  He helped raise the initial venture funding and served as the first head of sales, marketing, and planning.  After a successful launch he returned to the Boston area where he has been a founder of several other MIT-related startup ventures including Applied Expert Systems, Inc. (a spinout frrom Index Systems), Organogenesis, and others.

Ken is a member of the Council on Foreign Relations, the World Affairs Council, the Cercle Royal Gaulois Artistique & Literaire (Brussels), and the Quissett Yacht Club.  Prior to moving to Brussels, Ken was a member of the Board of the MIT Enterprise Forum of Cambridge®.  He currently serves on the Board of Directors of Optimum Logistics Ltd.

He serves as the Émile Bernheim Visiting Professor in Entrepreneurship, Solvay Business School, Université Libre de Bruxelles (ULB) (Brussels, Belgium) for the academic year 2001-2002.

Mass High Tech named Ken  “High Tech All-Star” for his contribution to entrepreneurship education.

When time permits, Ken and his family enjoy tennis and sailing their wooden boat.

March 2002

松本 正 氏  MATSUMOTO, Tadashi

株式会社レクメド 代表取締役


1976年       東京大学・薬学部薬学科卒業

1981年        東京大学大学院・薬学系研究科博士課程修了(薬学博士)

1992年        筑波大学大学院・経営・政策科学研究科修士課程修了(経営学修士)

1997年        スタンフォード・ビジネススクール・夏季エグゼクティブコース(2週間)修了


 1981年       協和発酵工業株式会社入社、東京研究所

1982年        米国National Institute of Health派遣(1年半)

1986年        加藤記念バイオサイエンス研究所

1989年        医薬研究開発センター・国際開発部門

1996年        医薬戦略企画部

1997年        医薬企画管理部

1998年       協和発酵と共に(株)レクメド設立し、代表取締役社長に就任

1999年       協和発酵を退社し、レクメド株の協和発酵持分を購入し完全独立

2000年      mblVCと共にライフサイエンス投資事業組合を設立しGPに就任

米国にReqMed Research, Inc.を設立し、President & CEOに就任

 Tadashi Matsumoto, Ph.D.

President and CEO and Chairman of Board of Directors

Dr. Matsumoto has more than 20 years of experience in the life science industries. He is a co-founder and the President and CEO of ReqMed Company, Ltd. since 1998. Dr. Matsumoto played a key role in helping to create the pioneer Japanese biotech fund, Life Science Venture Fund, of which ReqMed Company, Ltd. is a General Partner. He is also the founder and President and CEO of ReqMed Research, Inc. since November 2000. Currently, Dr. Matsumoto also serves as Chairman of the Board of Directors for both ReqMed Company, Ltd. and ReqMed Research, Inc. He also serves on X-mine’s Board of Directors as a Director. Prior to co-founding ReqMed, Dr. Matsumoto was involved with Research and Business Management at Kyowa Hakko Kogyo Co., Ltd. and held several key positions from 1986 – 1998. He has served at Kyowa as the Manager of Licensing and Business Development, Manager of Strategic Planning Department, and Manager of Pharmaceutical R&D Center of the International Division where he was involved in forming collaborations with major biopharmaceutical companies such as COR and Cephalon. Dr. Matsumoto has also held several Researcher positions at Kyowa as well. He was a Researcher at Kato Memorial Bio- Science Laboratories from April 1986 ? March 1989 where he researched new trends in Neuroscience for Kyowa. From April 1983 September 1984, Dr. Matsumoto worked as a Researcher at the National Institute of Mental Health in the United States on LCB, an anti-inflammation protein. Prior to NIH, Dr. Matsumoto worked as a Researcher at the Tokyo Research Laboratories from April 1981 March 1986 on establishing a high level of gene expression in E.coli and the isolation of new c-DNAs related to inflammation diseases. Dr. Matsumoto received his B.S., M.S., and Ph.D. from the Faculty of Pharmaceutical Science at the University of Tokyo and received his MBA from Tsukuba University. Dr. Matsumoto’s hobby is sushi. He is a sushi connoisseur and enjoys sharing his knowledge of the art with others.

土生哲也氏 HABU, Tetsuya

土生特許事務所 代表 (http://www1.cts.ne.jp/~habupat/

1989年京都大学法学部卒、日本開発銀行(現日本政策投資銀行)入行。1995年同行の新規事業支援室の創設メンバーとなり、 知的財産権担保によるベンチャー企業向け融資制度の創設に携わる。
1998年 同行より新規事業投資(政府系ベンチャーキャピタル)に出向、10社強のベンチャー投資を手掛け、これまでに4社が IPOを実現。2000年弁理士登録、2001年日本政策投資銀行を退職して土生特許事務所を設立。現在は、金融業、流通業、 ITベンチャーなど特許に馴染みの薄かった業種を中心に、知的財産関連のコンサルティング・出願業務を行っている。


第14回日本エンタープライズ・フォーラム ベンチャー企業成長支援セッション

第2回 成長企業の知的財産戦略  土生特許事務所 土生哲也氏

12月のフォーラムでは、ベンチャー事業成長支援セッションの第2回として、「ベンチャー企業が企業価値を高めるための知的財産戦略の構築」をテーマに掲げ、弁理士の 土生(はぶ)哲也氏にレクチャーをお願いしております(下記参照)。また前回に引き続き、今までビジネスプランコンテスト・イン・ジャパンで入賞された起業家をお招きし、 事業の近況報告をお願いしております。 ご都合の許す限り、この有意義なフォーラムに参加くださいますよう、ご案内いたします。


知的財産重視の時代背景の下、企業経営においても知的財産のマネージメントが重要なテーマとなっています。 我が国において、これまで特許を主とする知的財産業務は成熟した大手メーカーを中心に行われ、権利の取得が 自己目的化する傾向にありました。しかしながら、知的財産のマネージメントも、本来は「企業価値の向上」という 企業経営の目的に沿ったものであるべきです。また、ベンチャー企業などの成長企業は、自らのリソースにあった マネージメント手法を導入する必要があります。今回のセミナーでは、成長企業の性格に合った企業価値向上の ための知的財産戦略について、土生氏より説明いただきます。


日時: 2002年12月12日(木)18:30-21:00

場所: 天王洲セントラルタワー27階ホール


寺石 雅英 氏  TERAISHI, Masahide